“Pre-Treatment“ and “Post-Treatment” Systemic Inflammatory Markers: Is There Any Prognostic Role for Metastatic Cervical Cancer on Bevacizumab Containing Treatment?

“Pre-Treatment“ and “Post-Treatment” Systemic Inflammatory Markers: Is There Any Prognostic Role for Metastatic Cervical Cancer on Bevacizumab Containing Treatment?

<i>Background and Objectives</i>: Despite developments in cervical cancer (CC) treatment, an advanced stage is a poor prognostic factor. Cervical cancer is an immunogenic tumor in which viruses, like HPV, play a role in carcinogenesis. Therefore, systemic inflammatory markers (SIMs) may...

Full description

Saved in:
Bibliographic Details
Main Authors: Serkan Yaşar, Ahmet Kadıoğlu, Arif Akyildiz, Nadiye Sever, Mehmet Emin Büyükbayram, Mehmet Bilici, Elanur Karaman, Mehmet Uzun, Murat Bardakcı, Caglar Koseoglu, Irem Bilgetekin, Mehmet Cihan İçli, Alper Türkel, Zafer Arık, Murat Sarı, Tugba Yavuzsen, Mehmet Ali Nahit Sendur, İsmail Erturk, Mutlu Dogan
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Medicina
Subjects:
cervix
bevacizumab
systemic inflammatory markers
Online Access:https://www.mdpi.com/1648-9144/61/6/1100
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items